Chinese vaccine makers Sinovac, Sinopharm and CanSinoBio applied to join WHO's COVAX scheme


  • World
  • Wednesday, 20 Jan 2021

FILE PHOTO: Bottles of the Sinovac's vaccine for the coronavirus disease (COVID-19) are seen inside a vaccine carrier at a district health facility in Jakarta, Indonesia, January 19, 2021. REUTERS/Willy Kurniawan

BEIJING (Reuters) - Chinese COVID-19 vaccine developers Sinovac, Sinopharm and Cansino Bio have submitted application to join COVAX, a global schemed backed by the World Health Organization, foreign ministry spokeswoman Hua Chunying said on Wednesday.

(Reporting by Cate Cadell, editing by Louise Heavens)

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

ICC's arrest warrants for Netanyahu, Gallant appropriate, says Anwar
At least 10 killed in Afghanistan attack, interior ministry says
Factbox-What is Russia's 'Oreshnik' missile?
Explainer-How the US tracks ballistic missile launches
Greek police arrest man over arms cache in central Athens flat
Russian drone attack on Sumy kills two, injures 12, local authorities say
South Korea official says Russia provided anti-air missile to North Korea
Adani's Australian coal unit faces human rights complaint
Thai court rejects petition over ex-PM Thaksin's political influence
Taiwan's president to visit Tuvalu, Palau and Marshall Islands

Others Also Read